INBX Stock INBX is expected to report earnings to rise+40% to -104 cents per share on May 06

A.I.dvisor
at Tickeron.com
05/05/24
Loading...
INBX - Inhibrx
Inhibrx Earnings Graph
Q1'24
Est.
$-1.04
Q4'23
Missed
by $0.69
Q3'23
Missed
by $0.09
Q2'23
Missed
by $0.05
Q1'23
Missed
by $0.26
The last earnings report on December 31 showed earnings per share of -173 cents, missing the estimate of -104 cents. P/B Ratio (37.175) is normal, around the industry mean (10.284). P/E Ratio (0.000) is within average values for comparable stocks, (116.129). INBX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.466). INBX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (909.091) is also within normal values, averaging (233.049). With 246.60K shares outstanding, the current market capitalization sits at 1.62B.
View a ticker or compare two or three
INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in researching and developing biotechnology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
172
Web
https://www.inhibrx.com